Falck E, Karlsson S, Carlsson J, Helenius G, Karlsson M, Klinga-Levan K
J Clin Invest 121, 24802492, doi: 10.1172/JCI44932 (2011)
It delivers the healing peptide Body Protection Compound-157 through the nasal mucosa
From a broader perspective, this work challenges the traditional dogma that GPCRs activate single canonical pathways
4, 5 PRC2 inactivation may occur at some point during progression to higher grade malignant peripheral nerve sheath tumor, which is in accordance with the observation that in our study H3K27me3 expression was lost significantly more frequently in high-grade than in low/intermediate-grade tumors
Yuan D, Li X, Luo C, Li X, Cheng N, Ji H, Qiu R, Luo G, Chen C, Hei Z